Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

R. Ferreiro-Iglesias, A. Jardi, A. Quiroga, I. Baston, J. Gonzalez, J. M. Giraldez, I. Zarra, M. J. Lamas, J. E. Dominguez-Munoz, M. Barreiro-de Acosta

Producción científicarevisión exhaustiva

Idioma originalEnglish
Páginas (desde-hasta)S390-S391
PublicaciónJournal of Crohn's and Colitis
Volumen13
EstadoPublished - mar 2019

Citar esto